TNFSF11 and bacterial arthritis: Our preliminary data demonstrate that both monocyte depletion and a RANKL inhibitor fully prevent the joint destruction in septic arthritis, strongly suggesting that activated osteoclastogenesis is the main cause of joint damage in septic arthritis and targeting the key molecules in osteoclast activation may improve dramatically the treatment for joint damage in patients with septic arthritis.